This article is more than 5 years old. Information may no longer be current.

Integra LifeSciences receives 510k clearance for reverse shoulder system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Integra LifeSciences Holdings Corporation announced that it has received 510k clearance for its Integra Titan Reverse Shoulder System.

The Reverse Shoulder System is built on a platform stem that simplifies the conversion of a primary total shoulder, or hemi for fracture, to a reverse shoulder, without the need to remove a stem that is well-fixed in the patient’s bone. According to a company press release, the system offers fully interchangeable components, which allow all primary, reverse and fracture humeral bodies to be used with either the press-fit or cemented platform stems. This flexibility provides surgeons with minimally invasive intraoperative options, and the ability to offer continued care for the lifetime of the patient.

“The Reverse Shoulder System is an exciting addition to Integra’s shoulder portfolio, which includes the Total Shoulder System and the Humeral Resurfacing Arthroplasty System,” Robert Paltridge, president of Integra, Extremity Reconstruction, stated.